CPDD 78th Annual Scientific Meeting Program
2016-78th-CPDD-Program-Book-6-07-16FINAL
2016-78th-CPDD-Program-Book-6-07-16FINAL
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Tuesday, June 14, 2016<br />
99 Readiness to change is a predictor of reduced substance use involvement: Findings from a<br />
randomized controlled trial of patients attending South African emergency departments<br />
B. Myers 1 , D. J. Stein 2 , K. Sorsdahl 2 , 1 Alcohol, Tobacco and Other Drug Research Unit, South<br />
African Medical Research Council, Tygerberg, South Africa, 2 University of Cape Town, Cape<br />
Town, South Africa<br />
CLUB/DESIGNER DRUGS<br />
100 Dopaminergic mediation of the discriminative stimulus effects of three cathinone analogs of<br />
MDMA<br />
S. Dolan 2 , M. B. Gatch 1 , 1 Pharmacology & Neuroscience, UNT Health Science Center, Fort<br />
Worth, TX, 2 Institute for Healthy Aging, Center for Neuroscience Discovery, University of<br />
North Texas Health Science Center, Fort Worth, TX<br />
101 Entactogenic effects of synthetic cathinones<br />
M. B. Gatch, M. J. Forster, Center for Neuroscience Discovery, UNT Health Science Center,<br />
Fort Worth, TX<br />
102 Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and<br />
non-research settings<br />
T. M. Carbonaro, M. W. Johnson, R. R. Griffiths, Johns Hopkins University, Baltimore, MD<br />
103 Reliability and validity of the Japanese version of the DAST-2<br />
T. Shimane, T. Matsumoto, Department of Drug Dependence Research, National Institute of<br />
Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan<br />
STIMULANTS: ANIMAL STUDIES<br />
104 Participation of CC-Chemokine ligands in reward system on methamphetamine-induced<br />
psychological dependence in mice<br />
S. Kishioka 1 , F. Saika 1 , S. Matsuzaki 1 , M. Ko 2 , N. Kiguchi 1,2 , 1 Pharmacology, Wakayama<br />
Medical University, Wakayama, Japan, 2 Physiology and Pharmacology, Wake Forest<br />
University School of Medicine, Winston-Salem, NC<br />
105 Pharmacological effects of injected or vaporized methamphetamine and alpha-PVP in mice<br />
J. A. Marusich, T. Lefever, B. Blough, B. F. Thomas, J. Wiley, RTI International, Research<br />
Triangle Park, NC<br />
106 Combined effects of a serotonin 5HT2C receptor agonist and a serotonin 5HT2A receptor<br />
antagonist on methamphetamine-induced sleep disruption evaluated with actigraphy in rhesus<br />
monkeys<br />
L. F. Berro, M. Peres Diaz, M. L. Andersen, L. Howell, Emory University, Atlanta, GA<br />
107 Effects of lorcaserin on cocaine and methamphetamine self-administration and on reinstatement<br />
of extinguished responding in rhesus monkeys<br />
L. R. Gerak 1 , G. T. Collins 1,2 , C. P. France 1,3 , 1 Pharmacology, University of Texas Health<br />
Science Center, San Antonio, TX, 2 South Texas Veterans Health Care System, San<br />
Antonio, TX, 3 Psychiatry, University of Texas Health Science Center, San Antonio, TX<br />
108 Cocaine-cue memory extinction is associated with depotentiation at amygdala synapses<br />
M. T. Rich, T. Cahanap, Y. Huang, M. M. Torregrossa, University of Pittsburgh, Pittsburgh, PA<br />
109 Regulation of gene expression of the delta opioid receptor, corticotropin-releasing hormone,<br />
and CRH-1 receptor during withdrawal from chronic cocaine<br />
K. L. Connelly, E. M. Unterwald, Center for Substance Abuse Research, Temple University<br />
Lewis Katz School of Medicine, Philadelphia, PA<br />
110 Crabp2 and Fabp5 mediated retinoic acid signaling is a novel mechanism controlling<br />
depression- and addiction-related behavior<br />
Y. Zhang, E. Crofton, S. Koshy, T. Green, University of Texas Medical Branch, Galveston, TX<br />
64
Change language